These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 9934679)

  • 21. Sp1 is critical for basal and E2-transactivated transcription from the bovine papillomavirus type 1 P89 promoter.
    Sandler AB; Baker CC; Spalholz BA
    J Gen Virol; 1996 Feb; 77 ( Pt 2 )():189-98. PubMed ID: 8627222
    [TBL] [Abstract][Full Text] [Related]  

  • 22. BPV-4 E8 transforms NIH3T3 cells, up-regulates cyclin A and cyclin A-associated kinase activity and de-regulates expression of the cdk inhibitor p27Kip1.
    O'Brien V; Campo MS
    Oncogene; 1998 Jul; 17(3):293-301. PubMed ID: 9690511
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of the transforming functions of bovine papillomavirus type 4.
    Pennie WD; Grindlay GJ; Cairney M; Campo MS
    Virology; 1993 Apr; 193(2):614-20. PubMed ID: 8384749
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Optimizing gene expression in BPV-transformed cells: effects of cell type on enhancer/promoter interaction.
    Hurwitz DR; Hodges R; Drohan W; Sarver N
    Nucleic Acids Res; 1987 Sep; 15(17):7137-53. PubMed ID: 2821493
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transactivation of a bovine papilloma virus transcriptional regulatory element by the E2 gene product.
    Spalholz BA; Yang YC; Howley PM
    Cell; 1985 Aug; 42(1):183-91. PubMed ID: 2990724
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhancer-dependent expression of the rat preproinsulin gene in bovine papillomavirus type 1 vectors.
    Sarver N; Muschel R; Byrne JC; Khoury G; Howley PM
    Mol Cell Biol; 1985 Dec; 5(12):3507-16. PubMed ID: 3018523
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification and functional analysis of sequence variants in the long control region and the E2 open reading frame of bovine papillomavirus type 1 isolated from equine sarcoids.
    Nasir L; Gault E; Morgan IM; Chambers G; Ellsmore V; Campo MS
    Virology; 2007 Aug; 364(2):355-61. PubMed ID: 17412385
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification and functional analysis of sequence rearrangements in the long control region of human papillomavirus type 16 Af-1 variants isolated from Ugandan penile carcinomas.
    Tornesello ML; Buonaguro FM; Buonaguro L; Salatiello I; Beth-Giraldo E; Giraldo G
    J Gen Virol; 2000 Dec; 81(Pt 12):2969-2982. PubMed ID: 11086128
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multiple cooperative interactions constrain BPV-1 E2 dependent activation of transcription.
    Sowden M; Harrison S; Ashfield R; Kingsman AJ; Kingsman SM
    Nucleic Acids Res; 1989 Apr; 17(8):2959-72. PubMed ID: 2542891
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transcriptional termination between bovine papillomavirus type 1 (BPV-1) early and late polyadenylation sites blocks late transcription in BPV-1-transformed cells.
    Baker CC; Noe JS
    J Virol; 1989 Aug; 63(8):3529-34. PubMed ID: 2545923
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Production of infectious bovine papillomavirus from cloned viral DNA by using an organotypic raft/xenograft technique.
    McBride AA; Dlugosz A; Baker CC
    Proc Natl Acad Sci U S A; 2000 May; 97(10):5534-9. PubMed ID: 10805809
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evidence for cooperativity between E2 binding sites in E2 trans-regulation of bovine papillomavirus type 1.
    Spalholz BA; Byrne JC; Howley PM
    J Virol; 1988 Sep; 62(9):3143-50. PubMed ID: 2841467
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transcriptional activity of human papillomavirus type 16 variants having deletions in the long control region.
    Veress G; Murvai M; Szarka K; Juhász A; Kónya J; Gergely L
    Eur J Cancer; 2001 Oct; 37(15):1946-52. PubMed ID: 11576852
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activity of human papillomavirus type 16 P97 promoter in immortal and tumorigenic human oral keratinocytes.
    Kook JK; Kim JH; Min BM
    Int J Oncol; 1998 Oct; 13(4):765-71. PubMed ID: 9735407
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A mutational analysis of the transforming functions of the E8 protein of bovine papillomavirus type 4.
    O'Brien V; Ashrafi GH; Grindlay GJ; Anderson R; Campo MS
    Virology; 1999 Mar; 255(2):385-94. PubMed ID: 10069964
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Different arrangement of human papillomavirus E2 binding sites distinguishes cutaneous types from those associated with mucosal lesions.
    Garrido-Guerrero E; Carrillo E; Guido M; Zamorano R; García-Carranca A; Gariglio P
    Arch Med Res; 1996; 27(3):389-94. PubMed ID: 8854400
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Direct interaction between Sp1 and the BPV enhancer E2 protein mediates synergistic activation of transcription.
    Li R; Knight JD; Jackson SP; Tjian R; Botchan MR
    Cell; 1991 May; 65(3):493-505. PubMed ID: 1850324
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Many different papillomaviruses have low transcriptional activity in spite of strong epithelial specific enhancers.
    Sailaja G; Watts RM; Bernard HU
    J Gen Virol; 1999 Jul; 80 ( Pt 7)():1715-1724. PubMed ID: 10423140
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cell-type specific transcriptional activities among different papillomavirus long control regions and their regulation by E2.
    Ottinger M; Smith JA; Schweiger MR; Robbins D; Powell ML; You J; Howley PM
    Virology; 2009 Dec; 395(2):161-71. PubMed ID: 19836046
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhancer activation by a single type of transcription factor shows cell type dependence.
    Forsberg M; Westin G
    EMBO J; 1991 Sep; 10(9):2543-51. PubMed ID: 1714381
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.